The Hospitals of Providence Memorial Campus announced it is the first in El Paso to offer the DETOUR System, a treatment for ...

The superficial femoral artery is the most common site of atherosclerotic narrowing. In addition, aggressive use of bypass grafts has resulted in a greater number of patients presenting with acute ...

Following the successful completion of SIRONA--the largest superficial femoral artery (SFA) trial comparing our device against paclitaxel drug-coated balloons (DCBs), which demonstrated non ...

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that 1,000 patients ...

VentureMed Group, Inc., a medical device company focused on arteriovenous access and peripheral arterial disease, recently ...